Page last updated: 2024-11-13

greigite

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

greigite: component of magnetosomes (membrane-bound magnetic crystals) in bacteria that causes them to be oriented in magnetic fields; used as biomarkers [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

greigite : An iron sulfide mineral with formula Fe3S4. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID72720442
CHEBI ID86238
MeSH IDM0289719

Synonyms (6)

Synonym
greigite
greigite (fe3s4)
12063-39-7
CHEBI:86238
DTXSID20923500
Q27159021

Research Excerpts

Overview

Greigite is a Fe-S-containing complex. It has magnetic properties mainly synthesized in the solution.

ExcerptReferenceRelevance
"Greigite is a Fe-S-containing complex having magnetic properties mainly synthesized in the solution. "( Fabrication, characterization, and application of greigite nanoparticles for cancer hyperthermia.
Chang, YS; Hsu, CK; Lin, FH; Sadhasivam, S; Savitha, S, 2011
)
2.07
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (1)

RoleDescription
catalystA substance that increases the rate of a reaction without modifying the overall standard Gibbs energy change in the reaction.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (3)

ClassDescription
sulfide mineralAny mineral that contains sulfide (S(2-)) as the major anion.
iron(2+) sulfidesAny member of the class of iron sulfides in which the iron is in the (2+) oxidation state.
iron(3+) sulfidesAny member of the class of iron sulfides in which the iron is in the (3+) oxidation state.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (72)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's5 (6.94)18.2507
2000's15 (20.83)29.6817
2010's36 (50.00)24.3611
2020's16 (22.22)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 36.06

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index36.06 (24.57)
Research Supply Index4.29 (2.92)
Research Growth Index5.11 (4.65)
Search Engine Demand Index50.49 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (36.06)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews12 (16.67%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other60 (83.33%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]